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SUMMARY
Glutaredoxin 2 (Grx2) from Saccharomyces cerevisiae is a member of the 2-
Cys (dithiol) subfamily of glutaredoxins involved in the defense against oxidative
stress in yeast. Recombinant yeast Grx2p expressed in E. coli. behaves as a “classical”
glutaredoxin that efficiently catalyzes the reduction of hydroxyethyl disulfide by
GSH. Grx2p also catalyzes the reduction of GSSG by dihydrolipoamide with even
higher efficiency. Western blot analysis of S. cerevisiae crude extracts identifies two
isoforms of Grx2p of 15.9 and 11.9 kDa, respectively. The levels of these two
isoforms reach a peak during the exponential phase of growth in normal YPD medium,
with the long form predominating over the short one. From immunochemical analysis
of subcellular fractions it is shown that both isoforms are present in mitochondria but
only the short one is detected in the cytosolic fraction. On the contrary, only the long
form is prominent in microsomes. Mitochondrial isoforms should represent the
processed and unprocessed products of a new ORF (YDR513W) with a putative start
codon 99 bp upstream of the GRX2 start codon so far described. These results
indicate that GRX2 contains two in-frame start codons and that translation from the
first AUG results in a product which is targeted to mitochondria. The cytosolic form
would result either by initiation from the second AUG or by differential processing of
one single translation product.
INTRODUCTION
Glutaredoxins (Grx) are small proteins (»10 kDa), highly conserved
throughout evolution, which catalyze GSH-disulfide oxidoreductions [1]. The first
function assigned to glutaredoxin was as electron donor for the reduction of an
intramolecular disulfide in ribonucleotide reductase [2] by means of a dithiol
mechanism [3]. The active site sequence (Cys-Pro-Tyr-Cys) responsible for this
activity is conserved in most species. However, only one of these cysteines is
involved in other important reactions also catalyzed by Grx in vitro, such as the GSH-
dependent reduction of protein-glutathionyl-mixed disulfides (protein-SSG), the so
called deglutathionylase or dethiolase activity [4-6]. Since oxidative conditions induce
the accumulation of protein-SSG [7, 8], Grx may play a role in the defense of cells
against reactive oxygen species (ROS) by means of its dethiolase activity. Evidences
for a protective role of Grx under oxidative conditions have been reported from
biochemical [5, 6, 9, 10] and genetic [11, 12] approaches.
Two genes encoding glutaredoxins have been characterized in Saccharomyces
cerevisiae, GRX1 and GRX2, which share a high degree of similarity with other known
Grxs from different species [12, 13]. Grx1p and Grx2p appear to play different roles
in yeast, i.e., GRX1 mutants are sensitive to oxidative stress caused by superoxide
anion as induced by menadione whereas GRX2 mutants are sensitive to stress induced
by hydrogen peroxide; in addition, Grx2p accounts for most of the GSH-dependent
oxidoreductase activity in yeast cells [12]. Moreover, GRX1 and GRX2 show different
expression patterns under various stress conditions although both genes possess and
are regulated by STRE elements [14].
A group of three additional genes named GRX3, GRX4 and GRX5 with
homology to glutaredoxin have also been identified in yeast [11]. The proteins
encoded by these genes show a marked difference with other glutaredoxins in that they
only have one cysteine in the active site instead of two. This might be a substantial
property that would limit the action of this subfamily of glutaredoxins to processes
that occur through a monothiol mechanism. Mutants lacking any of these three
proteins showed a marked decrease ( » 60%) in Grx activity, as determined by the
standard assay in crude extracts, and were more prone to protein oxidative damage and
more sensitive to osmotic stress than the wild type. In addition, grx2 grx5 mutant
was non-viable indicating that Grx2p and Grx5p can functionally substitute for each
other; the triple mutation grx3grx4grx5 was also lethal [11].
A new mammalian glutaredoxin has been recently characterized that
specifically localizes in the mitochondria and the nucleus and is expressed in two
isoforms, one of them with an N-terminal extension that functions as mitochondrial
targeting signal [15, 16]. From an analysis of the genomic DNA sequence of
Saccharomyces cerevisiae we have observed that the grx2 gene coding for
glutaredoxin-2 (thioltransferase) [13] has a potential in frame start codon 99 bp
upstream of the so far described initial methionine, that would define a different ORF
(YDR513W) (Fig 1). YDR513W would code for a protein longer than Grx2p with a
N-terminal extension of 34 residues. To check whether this peptide constitutes a
mitochondrial signal we have studied the subcellular localization of Grx2p.
We show here that Grx2p can be targeted to mitochondria or to the cytosol,
and a mechanism that accounts for this differential localization is proposed and
discussed.
EXPERIMENTAL
Materials.
All reagents employed were of analytical grade and were purchased from
Sigma, unless otherwise specified.
Strains  and growth conditions.
The yeast strains FY1679 (MATa ura3-52 his3 D 200) and CML235 (MATa
ura3-52 leu2D 1 his3D 200) were used as wild types. grx2 (MML44) and grx5
(MML19) mutants were obtained from the wild type CML235 as described [11] and
were kindly provided by Dr. E. Herrero (Universitat de Lleida, Spain). Yeast cells
were grown at 30°C in YPD medium. E. coli BL21(DE3) was employed as a host for
DNA cloning.
Cloning and expression of recombinant yeast Grx2p.
Two primers were designed (yGrx2-NdeI, 5’-
CTACTCCACATATGGTATCCCAGGAAACAG-3’, forward and yGrx2-BamHI,
5’-TTAGCGGGATCCAAACTATTGAAATACC-3’, reverse) to clone the GRX2
gene according to the sequence obtained from the data base (Saccharomyces Genome
Data Bank, locus GLRX). The forward primer contained the initiation codon (bold
letters) and an NdeI site (underlined) and the reverse primer contained the stop codon
(bold letters) and a BamHI site (underlined). The primers were used to amplify S.
cerevisiae genomic DNA by PCR (35 cycles at 96°C for 1 min, 50°C for 1 min and
68°C for 1.5 min) with Expand Long Template System (Roche Molecular
Biochemicals). The PCR product was cloned into the pGEM-Te Vector System
(Promega) and sequenced. The amplified fragment was subcloned into the  pET-15b
expression vector (Novagen) fused at the N-terminus to a 20 aminoacid peptide
containing a polyhistidine tag and a thrombin cleavage site. The construct, named
pET-15b-Grx2(s) was verified by PCR using the above primers and E. coli cells were
transformed. Single colonies were selected and inoculated in LB medium containing 1
µg/ml ampicillin and were grown at 37°C until A600 = 0.5; the recombinant protein
was induced with 0.5 mM IPTG and the cells were kept growing at room temperature
overnight. Collection, lysis and crude extract preparation was performed as described
[17]. His-tagGrx2p was purified from the extract by chromatography on a Talon
Resin column (Clontech) and the His-tag was subsequently removed by controlled
incubation with thrombin, as described before [18].
Assay of enzymatic activities.
Glutaredoxin activity was determined spectrophotometrically by measuring
the reduction of 0.5 mM HED (Aldrich Chemicals) by 0.5 mM GSH in the presence
of NADPH and 0.5 Units of yeast glutathione reductase (Sigma G-3664) at room
temperature following the disappearance of NADPH at 340 nm [19]. One unit is
defined as the oxidation of one µmol NADPH/min. Peroxidase activity was
determined by substituting HED with peroxide substrates as indicated where
appropriate.
Glutaredoxin dependent reduction of 0.5 mM GSSG by 0.64 mM
dihydrolipoamide, was measured spectrophotometrically in the presence of 0.36 mM
NADH and 1.7 Units of lipoamide dehydrogenase (Sigma L-2002), following the
disappearance of NADH at 340 nm. One unit of dihydrolipoamide-GSSG reductase
activity is defined as the oxidation of one µmol of NADH/min. Organelle marker
enzymes were assayed according to published procedures: cytochrome c oxidase [20]
was used as a mitochondrial marker, glucose-6-phosphate dehydrogenase [21] as a
cytosolic marker and NADPH-cytochrome c reductase as a microsomal marker [22].
Preparation and purification of polyclonal antibodies to yeast Grx2p.
Recombinant Grx2p was used to immunize New Zealand albino rabbits
according to Harboe and Ingild [23]; it was immobilized onto CNBr-activated
Sepharose-4B (Amershan Pharmacia) and packed in a column. Immune sera were
loaded and recycled several times; after washing with 2 M NaCl, elution was afforded
with 0.5 M formic acid followed by rapid neutralization with 2 M Trizma.
Subcellular fractionation of yeast cells.
Cells of S. cerevisiae grown in YPD medium until stationary phase were
harvested and subjected to subcellular fractionation as described [24]. Spheroplasts
were prepared incubating with 0.5 mg/g cells lyticase in 20 mM potassium phosphate,
pH 7.4 containing 1.2 M sorbitol. Spheroplasts were harvested by centrifugation,
diluted in 20 mM MES-KOH pH 6.0,  0.6 M sorbitol, 0.5 mM PMSF (buffer A) and
disrupted in a Dounce homogenizer. The crude mitochondrial fraction was separated
by differential centrifugation with buffer A and finally collected at 12,000 x g and
suspended in buffer A. The purity of this mitochondrial preparation was further
increased by ultracentrifugation in 14% - 18% Nycodenz (Sigma). Centrifugation at
100,000 x g for 1.5 h provided the cytosolic fraction, which was dialyzed against 20
mM Tris-HCl pH 8.0, 0.1 M NaCl; and the microsomal fraction, which was
suspended in 50 mM potassium phosphate pH 7.4, 0.1 M NaCl.
SDS-PAGE and Western blotting.
SDS-PAGE was performed on homogenous 15% acrylamide gels followed by
Coomassie staining or electrophoretic semi-dry transfer to nitrocellulose membranes.
The membranes were processed by the method of Towbin [25]. The primary
antibodies were used at 1:500 dilution and developed with the chemiluminiscence ECL
system (Amershan Pharmacia). The amount of Grx in the blots was calculated
densitometrically (Syngene) using pure Grx as standard.
Protein concentration was determined spectrophotometrically [26] (Bio-Rad)
using ovoalbumin as standard.
RESULTS
Sequence analysis of yeast Grx2.
Analysis of genomic DNA of Saccharomyces cerevisiae around GRX2 gene
shows an in frame start codon 99 nucleotides upstream of the canonical ATG (ORF
YCL035C), that defines ORF YDR513W (Fig 1A). Translation of this new ORF
would produce a 15.9 kDa protein similar to the so far described yeast Grx2 bearing a
34 residue N-terminal extension peptide. Prediction of subcellular localization using
TragetP [27] identifies residues 1-34 as a signal peptide. This signal peptide bears a
highly hydrophobic stretch between residues 9 and 26, is rich in basic residues, with a
theoretical pI=10.0 (Fig 1), which are usual features of peptides bound for targeting
and translocation to mitochondria [28]. Curiously enough, this presequence has acidic
residues, but despite this unusual property the signal peptide meets most of the
requirements to be a substrate of mitochondrial processing peptidase (MPP) [29] (Fig
1B). These include a set of three basic distal residues that will be located at the same
side of an a -helix thus allowing interaction with the a  subunit of MPP; a helix-linker-
helix structure around the breaking peptide bond that would be between M35 and
V36; a hydrophobic and a hydroxyl pair of residues at 1 and 2 positions relative to the
cleavage site;  and a proximal basic residue at -2 position relative to the cleavage site,
arginine in the consensus pattern, but here substituted by lysine.
cDNA cloning, purification and characterization of recombinant Grx2p.
Grx2 expressed as His-tagged derivative was purified from bacteria by affinity
chromatography on a Talon-metal affinity column. It was subsequently subjected to
controlled digestion by thrombin to remove the His tag, as described in Experimental.
The purity and size of the protein was verified by SDS-PAGE (Fig. 2A).
Recombinant Grx2p was tested for its ability to catalyze thiol-disulfide
oxidoreductions by means of the usual standard assay of Grx and was compared to
human Grx1. Grx2p efficiently catalyzes the reduction of HED by GSH (59.4 ± 6.6
U/mg; kcat=713 min-1) though with lower efficiency than that of human Grx1(180 ±
21.8 U/mg) and rat Grx1 (137.8 ± 39.6 U/mg) under equivalent conditions, but higher
than that of human Grx2 (37 ± 1 U/mg [16]; 3 U/mg [15]). Reduction of GSSG by
dihydrolipoamide, was catalyzed by yeast Grx2p with high efficiency (71.5 ± 23.9
U/mg; kcat=858 min-1). A recombinant truncated form of Grx5p that lacks 18 residues
at the N- terminus was also produced and proved completely unable to catalyze any
of the reactions tested above (data not shown). Since Grx5 and Grx2 have been
ascribed protective antioxidant roles [11] and it has been shown that Grx acts as
electron donor for human plasma GSH-Peroxidase [30], we also tested for the
reduction of three peroxides, cumene-, tert-butyl- and hydrogen peroxides. None of
the proteins showed any trace of peroxidase activity.
Recombinant Grx2p was used to obtain polyclonal antibodies from rabbits and
to purify them by immunoaffinity chromatography. The affinity purified anti-Grx2p
preparation was used to study the expression of the protein in cells of Saccharomyces
cerevisiae by Western blotting (Fig. 2B). Anti-Grx2 antibodies recognize two bands in
Western blots of S. cerevisiae cells: one larger (15.9 kD) than recombinant Grx2p and
one that coincides (11.9 kD). The proteins are expressed in wild type and grx5 strains
in the stationary phase; as expected, the grx2 mutant is negative with anti-Grx2
demonstrating that both bands are products of GRX2. Therefore yeast Grx1p, which
is present in all three strains, does not cross-react with the antibodies. The same lack
of cross-reactivity is also true for Grx5p and human Grx1 (Fig. 2B).
We have also followed the levels of both isoforms along the normal growth in
YPD medium and have found that both proteins reach a peak during the exponential
phase but their relative proportions vary, the long form being predominant at the
exponential phase (see Fig 3).
Subcellular localization of Grx2.
Cells of S. cerevisiae grown to stationary phase were collected and
subjected to subcellular fractionation as described in Experimental. Preparations of
cytosolic and mitochondrial fractions were obtained by differential centrifugation and
crossed contamination between them was unequivocally discarded as judged by their
levels of marker enzymes (Table 1). As expected, a subfraction of the endoplasmic
reticulum, the so called mitochondria-associated membrane (MAM) [31], co-isolates
with mitochondria. The microsomal fraction showed “membrane leakage” from other
subcellular fractions.
A Western blot analysis was performed with affinity purified anti-Grx2
antibodies and from the results shown in Fig. 4. we conclude that both isoforms of
Grx2p localize in mitochondria. The above mentioned two bands observed in crude
extracts of S. cerevisiae are present in the mitochondrial fraction, whereas only the
short form is detected in the cytosolic fraction and only the long isoform is
predominantly detected in microsomes.
DISCUSSION
Grx2p, the product of ORF YCL035C from Saccharomyces cerevisiae, has
been cloned and its subcellular distribution has been studied by Western blotting. In
doing so, we have detected two isoforms of different sizes, expressed at the same time
in yeast cells.
When compared to other Grx2 from human, rat and mouse, yeast Grx2p
shows  29% -30.5% similarity. The mature protein devoid of presequence has a
pI=5.76, more acidic than the majority of mammalian Grxs but conserves all the
structural features that define a 2-Cys (dithiol) subfamily of glutaredoxins [32]
including the catalytic site, the glutathione binding site and structurally important
hydrophobic domains (Fig. 5). However, at difference with other Grx2, yeast Grx2p
has conserved proline at the active site instead of serine [15, 16].
Recombinant Grx2p also displays all the catalytic properties of glutaredoxins
[33]. Its catalytic efficiency in the standard assay is lower than that of human and rat
Grx1, despite its 100% identity at the active site motif CPYC, but higher than that of
human Grx2 in which active site Pro is substituted by Ser. Lack of glutathione
peroxidase activity is a striking property of Grx2p in the light of a recent report [34]
in which Grx1p catalyzes peroxide reduction by GSH. These data further support the
proposed functional differences between both yeast dithiol glutaredoxins [14].
On the other hand, yeast Grx2 is very efficient as a dihydrolipoamide GSSG
oxidoreductase, what may be of interest for a mitochondrial enzyme. Actually, the
ratio of this activity to the standard GSH-HED oxidoreductase activity is higher in the
mitochondrial than in the cytosolic fraction. Lipoic acid is a redox coenzyme of several
enzymes and multienzyme complexes localized in mitochondria. A link between lipoic
and glutathione pools in the mitochondria would have interesting consequences in the
context of antioxidant defense and Grx could afford the connective role.
The 11.9 kDa isoform detected in the cytosolic fraction would represent the
putative product of YCL035C, (Fig. 1) i.e., the “classical” yeast glutaredoxin
(thioltransferase) initially described and studied by Gan and coworkers [13] with
resemblance to Grx1 from other organisms, which lack any organelle targeting
presequence. However, translation from the second AUG has to be confirmed by
further experiments.
The hydrophobicity of the presequence may be responsible for membrane
leakage and the presence of the long isoform in the microsomal fraction. It would be of
interest to ascertain whether the membrane associated form is actually an immature
species trapped in the mitochondrial import machinery or it plays specific roles in
membranes.
Nuclear-encoded mitochondrial proteins are synthesized as larger precursor
molecules that, upon import into mitochondria, are subject to proteolytic cleavage,
The two Grx2p isoforms present in mitochondria should correspond to the processed
and unprocessed products of a transcript encoding a N-terminal mitochondrial target
peptide. ORF YDR513W fulfills this requirement as described above (see Fig. 1). The
size of the long isoform detected in crude extracts and in mitochondrial and
microsomal subcellular fractions agrees with the size of a putative peptide resulting
from translation of YDR513W.
The presence of two forms of Grx2 in the mitochondrial fraction would be due
to differences in the rates of membrane translocation and proteolytic processing of one
single translation product by matrix peptidases. The rationale for this explanation is
based on similarities with yeast fumarase, for which a fraction of the protein folds
outside mitochondria into an import incompetent state that upon cleavage is released
by retrograde movement into the cytosol [28]. The rate of proteolytic cleavage could
be intrinsically slow for Grx2p due to the presence of Lysine at -2 position relative to
the cleavage site, instead of Arginine, since it is known that substitution of this
Arginine in model peptides greatly decreases the efficiency of the protease [29]. Slow
processing would then allow for Grx2p to fold before import and would thus return to
the cytosol. Only the fraction of Grx2p that is cleaved before folding would be
imported into the matrix. This is our working hypothesis for further research.
Alternative splicing is the mechanism that operates in mammals to target Grx2
either to the mitochondria or to the nucleus [15, 16]. In Saccharomyces cerevisiae,
whose coding DNA is not interrupted by introns, more rudimentary solutions seem to
operate that consist of either overlapping ORFs and alternative AUG selection [35,
36] or slow processing and retrograde movement [37, 38], as might be the case for
Grx2 as discussed above. An intermediate situation may function in the fission yeast
Schizosaccharomyces pombe, whose glutaredoxin gene contains three introns [39] and
also bears an "additional" in-frame start codon 90 bp upstream of the "main" start
codon (GeneBank S. pombe genomic DNA). Furthermore, the use of alternative
translation initiation sites combined with alternative splicing may increase the
complexity of the population of Grx isoforms as has been suggested recently [15].
Whether translation occurs from both start codons or there exists one single
translation product, and what possible regulatory mechanisms might be involved to
control the proportion of cytosolic and mitochondrial isoforms, are interesting
questions for further investigations, that will shed more light on novel ways to control
postgenomic events in eukariotic cells.
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LEGENDS TO THE FIGURES
Figure 1: Sequence analysis of Grx2p from Saccharomyces cerevisiae. A).
The upper line shows a stretch of genomic DNA sequence of S. cerevisiae comprising
two start codons that define open reading frames YDR513W and YCL035C (as
indicated. The N-terminal putative presequence is shadowed and the calculated
molecular weight of the protein is indicated. B) Analysis of the N-terminal extension..
Structural requirements that define this sequence as a precursor recognized and cleaved
by matrix processing peptidase are indicated according to  Ito (1999) [29] Number and
position of distal basic residues vary among known extension peptides, whereas the
most frequent proximal basic residue is arginine. A helix-linker-helix structure is
needed for effective cleavage of precursors. Predicted secondary structure is also
indicated underneath.
Figure 2. SDS-PAGE of purified recombinant Grx2p and Western
detection in crude extracts. A) After IPTG induction, the protein was purified as
the polyHis-Grx2 and was digested with thrombin under controlled conditions to
eliminate the PolyHis tag. Lane 1, Bio-Rad pre-stained molecular weight markers; lane
2, Grx2p. Protein was stained with Coomassie Blue. B) Samples from cells of S.
cerevisiae grown in YPD medium to stationary phase were collected by
centrifugation, suspended in electrophoretic sample buffer and subjected to Western
blot analysis with anti-Grx2 antibodies as described in Experimental. Lanes 1 and 8,
unstained Mr markers; lane 2, 0.1 µg of yeast Grx2p; lane 3, 0.15 µg of yeast Grx5p;
lanes 4 – 6, 20 µl of crude extracts from wt, grx2 and grx5 mutant strains,
respectively; lane 7, 0,1 µg of human recombinant Grx1.
Figure 3. Expression of Grx2p along the growth of Saccharomyces
cerevisiae in YPD medium. . A) 1 ml aliquots were withdrawn from the growth
medium at intervals along the growth curve and were analyzed by Western blotting as
indicated in Experimental: lanes 1 and 7, 0.1 µg of Grx2p; lanes 2 – 6, samples of 20 µl
taken at equivalent points from early exponential to late stationary growth phases for
all three strains. B) Growth curve of wild type S. cerevisiae and concentration of long
and short isoforms of Grx2p determined by quantitative densitometry from the blots
expressed as ng/A600nm. u--u, absorbance at 600 nm; s--s, Grx2p long isoform;   l-
-l, Grx2p short isoform; n--n, total Grx2p.
Figure 4. Localization of Grx2p in subcellular fractions of Saccharomyces
cerevisiae. Mitochondrial (mit), cytosolic (cyt) and microsomal (micr) fractions were
obtained from cells of S. cerevisiae grown to stationary phase as described in
Experimental. 25µg protein from each fraction was loaded onto SDS-PAGE and
analyzed by Western blotting. 50 ng of Grx2p were included as a reference; MW,
molecular weight standards.
Figure 5. Aminoacid sequence alignment of yeast Grx2 with human, rat
and mouse Grx2. Mitochondrial and nuclear human Grx2 are shown [Lundberg, 2001
#206]. Residues conserved in at least three of the aligned sequences are boxed. S1
indicates the active site and S2 the glutathione binding site. Translation initiation sites
of ORFs YDR513W and YCL035C are indicated by arrows.
Table 1. Enzymatic activities of subcellular fractions of Saccharomyces
cerevisiae. The activities were measured by the methods described in the Experimental
section. (1) Standard assay for Grx, that is the rate of HED reduction by GSH. (2) Rate
of GSSG reduction by dihydrolipoamide. (3) The ratio of both activities. The data
presented are the mean values ± s.d. of independent experiments, n = 3.
Specific activities (mU/mg)
Grx
Subcellular
fraction
NADPH
cyt c
R’ase
G6PDH Cyt c
oxidase HED1 Lipoamide2 Lip/HED3
Cytosol     5 ± 4 68 ± 1 0 98 ± 4 32 ± 4 0.3
Mitochondria 28 ± 14 0 46 ± 13 28 ± 5 28 ± 0.1 1
Microsomes 18 ± 8 10 ± 3 13 ± 4 5 ± 0.2 67 ± 3 13.4
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LEGENDS TO THE FIGURES
Figure 1: Sequence analysis of Grx2p from Saccharomyces cerevisiae. A).
The upper line shows a stretch of genomic DNA sequence of S. cerevisiae comprising
two start codons that define open reading frames YDR513W and YCL035C (as
indicated. The N-terminal putative presequence is shadowed and the calculated
molecular weight of the protein is indicated. B) Analysis of the N-terminal extension..
Structural requirements that define this sequence as a precursor recognized and cleaved
by matrix processing peptidase are indicated according to  Ito (1999) [29] Number and
position of distal basic residues vary among known extension peptides, whereas the
most frequent proximal basic residue is arginine. A helix-linker-helix structure is
needed for effective cleavage of precursors. Predicted secondary structure is also
indicated underneath.
Figure 2. SDS-PAGE of purified recombinant Grx2p and Western
detection in crude extracts. A) After IPTG induction, the protein was purified as
the polyHis-Grx2 and was digested with thrombin under controlled conditions to
eliminate the PolyHis tag. Lane 1, Bio-Rad pre-stained molecular weight markers; lane
2, Grx2p. Protein was stained with Coomassie Blue. B) Samples from cells of S.
cerevisiae grown in YPD medium to stationary phase were collected by
centrifugation, suspended in electrophoretic sample buffer and subjected to Western
blot analysis with anti-Grx2 antibodies as described in Experimental. Lanes 1 and 8,
unstained Mr markers; lane 2, 0.1 µg of yeast Grx2p; lane 3, 0.15 µg of yeast Grx5p;
lanes 4 – 6, 20 µl of crude extracts from wt, grx2 and grx5 mutant strains,
respectively; lane 7, 0,1 µg of human recombinant Grx1.
Figure 3. Expression of Grx2p along the growth of Saccharomyces
cerevisiae in YPD medium. . A) 1 ml aliquots were withdrawn from the growth
medium at intervals along the growth curve and were analyzed by Western blotting as
indicated in Experimental: lanes 1 and 7, 0.1 µg of Grx2p; lanes 2 – 6, samples of 20 µl
taken at equivalent points from early exponential to late stationary growth phases for
all three strains. B) Growth curve of wild type S. cerevisiae and concentration of long
and short isoforms of Grx2p determined by quantitative densitometry from the blots
expressed as ng/A600nm. u--u, absorbance at 600 nm; s--s, Grx2p long isoform;   l-
-l, Grx2p short isoform; n--n, total Grx2p.
Figure 4. Localization of Grx2p in subcellular fractions of Saccharomyces
cerevisiae. Mitochondrial (mit), cytosolic (cyt) and microsomal (micr) fractions were
obtained from cells of S. cerevisiae grown to stationary phase as described in
Experimental. 25µg protein from each fraction was loaded onto SDS-PAGE and
analyzed by Western blotting. 50 ng of Grx2p were included as a reference; MW,
molecular weight standards.
Figure 5. Aminoacid sequence alignment of yeast Grx2 with human, rat
and mouse Grx2. Mitochondrial and nuclear human Grx2 are shown [Lundberg, 2001
#206]. Residues conserved in at least three of the aligned sequences are boxed. S1
indicates the active site and S2 the glutathione binding site. Translation initiation sites
of ORFs YDR513W and YCL035C are indicated by arrows.
Table 1. Enzymatic activities of subcellular fractions of Saccharomyces
cerevisiae. The activities were measured by the methods described in the Experimental
section. (1) Standard assay for Grx, that is the rate of HED reduction by GSH. (2) Rate
of GSSG reduction by dihydrolipoamide. (3) The ratio of both activities. The data
presented are the mean values ± s.d. of independent experiments, n = 3.
Specific activities (mU/mg)
Grx
Subcellular
fraction
NADPH
cyt c
R’ase
G6PDH Cyt c
oxidase HED1 Lipoamide2 Lip/HED3
Cytosol     5 ± 4 68 ± 1 0 98 ± 4 32 ± 4 0.3
Mitochondria 28 ± 14 0 46 ± 13 28 ± 5 28 ± 0.1 1
Microsomes 18 ± 8 10 ± 3 13 ± 4 5 ± 0.2 67 ± 3 13.4
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